Molecular mechanisms of tumor plasticity

Tumor plasticity, epigenetic reprogramming and the dynamic tumor microenvironment shape the biology of CRC, AML and melanoma and influence their therapeutic vulnerability. Modern therapeutic approaches combine molecular profiles, TME signatures and functional biomarkers to break through resistance programs and enable more precise, patient-specific therapies.